Department of Cardio, Vascular and Thoracic Surgery
Odense, Region Syddanmark, 5000, Denmark
NCT Number: NCT05562908
It is to date unknown whether Thunderbeat has a place in harvesting the left internal mammary artery (LIMA) and whether skeletonisation is superior to pedicle harvested LIMA. Though, some studies have shown improved flow-rates in the skeletonised graft while others shows compromised blood flow to the thoracic wall after pedicle harvested LIMA.
The purpose of this study is to improve the quality of life for patients undergoing coronary artery bypass graft (CABG) operations.
The aim of this study is to compare three groups of LIMA harvesting techniques: Pedicled, surgical skeletonised and skeletonised with Thunderbeat to determine the best way to harvest LIMA during CABG operations.
The study design is an experimental randomized controlled trial in a single centre.
Study population: Adult patients enlisted for elective stand-alone CABG surgery at the Department of Cardiothoracic surgery, Odense University Hospital.
Study Unit: Test-days within subject and subject
The study will address two main hypotheses in CABG patients:
1. That both the surgical skeletonised and Thunderbeat skeletonised harvesting techniques of LIMA are superior to pedicled harvesting in regards to flowrates and pulsatility index (PI). 2. Skeletonized harvesting of LIMA graft compared to pedicled harvesting improves patient quality of life three days, 30 days, and six months postoperatively.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Odense, Region Syddanmark, 5000, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical procedure: A prior marking was made on both sides of the LIMA and its veins with bi-polar technique. Hereafter the LIMA and its veins were dissected free with scissor and forceps. Clips were added to all side branches. When the full length of LIMA was obtained, the LIMA and its veins were divided distally by adding clips on the peripheral part of the vessels and proximately dividing by scissor. A vessel-clamp was placed distally and the pedicled LIMA placed in the jugular cavity with a cloth containing papaverine.
Surgical procedure: The fascia of the LIMA was opened with a scissor. Hereafter the LIMA was dissected free with scissor and forceps, clips on all LIMA side-branches and divided by scissor. When the full length of LIMA was obtained, the LIMA was divided distally by adding clips on the peripheral part of the vessel and proximately dividing by scissor. A vessel-clamp was placed distally, and the skeletonised LIMA placed in the jugular cavity with a cloth containing papaverine.
Surgical procedure: With Thunderbeat the fascia of LIMA was opened. The LIMA was dissected free with Thunderbeat including all side-branches. When the full length of the LIMA was obtained, the LIMA was divided distally by adding clips on the peripheral part of the vessel and proximately dividing by scissor. A vessel-clamp was placed distally, and the skeletonised LIMA placed in the jugular cavity with a cloth containing papaverine.
Time frame: Perioperative - After weaning off the extracorporeal circulation just before closing the thorax
mL/ min With transit time flowmetry (Sono TT flowlab), the graft flow and peripheral index (PI) are measured after weaning off the extracorporeal circulation with a systolic pressure aimed at 100 mmHg. The measurements are done with probe size 3 or 4.
Time frame: Postoperative bleeding is measured from the end of the operation to removal of the mediastinal drains in the intensive care unit
Unit: mL
Time frame: Up to 48 hours calculated from the end of primaery surgery
Number of patients in each group
Time frame: Up to 48 hours calculated from the end of primaery surgery
Number of patients in each group
Time frame: Up to 10 days calculated from the end of primaery surgery
Number of patients in each group
Time frame: Routine bloodsample measured four hours after aortic cross clamp removal.
Unit: (µg/L)
Time frame: Routine bloodsample measured four hours after aortic cross clamp removal.
Unit: (ng/L)
Time frame: Measured 7 days prior to surgery and again 3 days after surgery
Unit: oxygen saturation (rSO2)
Time frame: Day of surgery to the day of discharge from ICU. Up to 52 weeks
Unit: Days
Time frame: Day of surgery to the day of discharge from hospital. Up to 52 weeks
Unit: Days
Time frame: Questionnaires uptained the week before the date of surgery and again 3, 30, and 180 days after surgery.
Developed by the EURO-QoF group in 1990 to describe five dimensions of quality of life: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels: no problems, slight problems, moderate problems, severe problems and extreme problems and a visual analogue scale recording the patient's self-rated health.
Time frame: 180 ± 7 days calculated from the date of surgery.
All questions are closed questions and qualitative variables (yes/no)
Time frame: Early (≤30 days)
Number of deaths in each group
Time frame: Intermediate (≤180 days)
Number of deaths in each group
Time frame: Long (≤2 years)
Number of deaths in each group
Time frame: Early (≤30 days)
Number of deaths in each group
Time frame: Intermediate (≤180 days)
Number of deaths in each group
Time frame: Long (≤2 years)
Number of deaths in each group
Time frame: Early (≤30 days)
Number of deaths in each group
Time frame: Intermediate (≤180 days)
Number of deaths in each group
Time frame: Long (≤ 2 years)
Number of deaths in each group
Lars Peter Riber
Other
Skeletonised Versus Pedicled Internal Thoracic Artery - A Randomised Study
Acronym: TST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT06154265
Arterial Occlusive Diseases, Arteriosclerosis
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT03138603
Arterial Occlusive Diseases, Arteriosclerosis
Chicago, Illinois, United States
View Trial DetailsNCT06358508
Arterial Occlusive Diseases, Arteriosclerosis
Stanford, California, United States
View Trial Details